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Transplantation offers a means of identifying the differentiation
and myelination potential of early neural precursors, features
relevant to myelin regeneration in demyelinating diseases. In
the postnatal rat brain, precursor cells expressing the polysia-
lylated (PSA) form of the neural cell adhesion molecule NCAM
have been shown to generate mostly oligodendrocytes and
astrocytes in vitro (Ben-Hur et al., 1998). Immunoselected PSA-
NCAM1 newborn rat CNS precursors were expanded as clus-
ters with FGF2 and grafted into a focal demyelinating lesion in
adult rat spinal cord. We show that these neural precursors can
completely remyelinate such CNS lesions. While PSA-NCAM1
precursor clusters contain rare P751 putative neural crest pre-
cursors, they do not generate Schwann cells in vitro even in the
presence of glial growth factor. Yet they generate oligodendro-
cytes, astrocytes, and Schwann cells in vivo when confronted
with demyelinated axons in a glia-free area. We confirmed the
transplant origin of these Schwann cells using Y chromosome
in situ hybridization and immunostaining for the peripheral my-
elin protein P0 of tissue from female rats that had been grafted
with male cell clusters. The number and distribution of
Schwann cells within remyelinated tissue, and the absence of
P0 mRNAs in donor cells, indicated that Schwann cells were
generated by expansion and differentiation of transplanted
PSA-NCAM1 neural precursors and were not derived from
contaminating Schwann cells. Thus, transplantation into demy-
elinated CNS tissue reveals an unexpected differentiation po-
tential of a neural precursor, resulting in remyelination of CNS
axons by PNS and CNS myelin-forming cells.
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Demyelinating diseases of genetic, viral, and/or autoimmune
origin such as multiple sclerosis are characterized by progressive
or recurrent episodes of focal demyelination that can result in
important neurological impairment. There is therefore much
interest in finding ways to stimulate remyelination of CNS demy-
elinated axons. Progress in this field has come from studies on the
development of oligodendrocytes, the CNS myelin-forming cells,
and on myelin regeneration in a variety of animal models with
and without transplantation of glial cells (Dubois-Dalcq and
Armstrong, 1990; Franklin and Blakemore, 1997; Duncan, 1996;
Fazekerley et al., 1997; Ludwin, 1997). From such studies glial
cell transplantation emerges, not only as a powerful tool for
investigating aspects of glial cell biology but also as a potential
therapeutic approach for human demyelinating disorders. If glial
cell transplantation is to be applied in a clinical setting, the
transplanted cells should have the potential for expansion both in
vitro and in vivo. Because the rate of division and regenerative
capacity of oligodendrocyte lineage cells decreases with differen-
tiation (Pfeiffer et al., 1993), there is increased interest in the use
of early precursors of oligodendrocytes as a source of donor cells
in transplantation studies. In the rodent brain, gliogenesis mostly
occurs postnatally, with precursors migrating out of the periven-
tricular zone to generate oligodendrocytes in the white matter
and astrocytes in the cortex (Goldman, 1995). It is at that time
that one can isolate and immunoselect neural precursors from the
rat brain expressing the embryonic polysialylated form of the
neural cell adhesion molecule (PSA-NCAM) (Trotter et al., 1989;
Grinspan and Franceschini, 1995). When grown on a nonadher-
ent substrate in the presence of FGF2 and thyroid hormone, these
PSA-NCAM1 neural precursors generate clusters resembling
neurospheres (Ben-Hur et al., 1998). When transferred to an
adherent substrate, these precursors differentiate mostly into as-
trocytes and oligodendrocytes (Ben-Hur et al., 1998). The pres-
ence of the PSA moiety on NCAM is not specific for glial
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precursors; rather, it indicates enhanced plasticity of these pre-
cursor cells and/or a restriction of their fate (Ben-Hur et al.,
1998).
In the present study, we have investigated the differentiation
and remyelination potential of PSA-NCAM1 neonatal neural
precursor clusters after transplantation in a focal demyelinating
lesion. Demyelination was induced chemically in adult rat spinal
cord after x-irradiation to suppress the remyelination that nor-
mally follows demyelination (Blakemore and Patterson, 1978).
This treatment leaves a population of demyelinated axons in a
glia-free environment that can be used to evaluate the remyeli-
nating and differentiation potential of transplanted glial cell pop-
ulations without the need to use markers to identify donor cells.
We found that PSA-NCAM1 neural precursors remyelinated this
lesion very efficiently and that, surprisingly, remyelination was
carried out by both oligodendrocytes and Schwann cells. Before
transplantation, PSA-NCAM1 clusters contain a small number of
cells expressing the low-affinity NGF receptor, and these may
represent neural crest or early Schwann cell precursors. However,
Schwann cell generation from these precursors was not detected
in vitro, even in the presence of glial growth factor 2 (GGF2),
which promotes Schwann cell growth. In contrast, when PSA-
NCAM1 neural precursors were transplanted into a demyelinat-
ing environment in the adult CNS, they generated large numbers
of Schwann cells, suggesting that the full differentiation potential
of neural precursors may sometimes be revealed only by an in vivo
environment.
MATERIALS AND METHODS
Immunopurification, culture, and immunostaining of PSA-NCAM neural
precursors. For all the transplantation experiments, the selection of PSA-
NCAM1 cells from mixed glial cell cultures derived from day 1 postnatal
inbred Lewis rat pups was performed after 3 d as previously described
(Ben-Hur et al., 1998). We dissected the cerebral hemispheres, including
the periventricular zone and deep nuclei, whereas the olfactory bulbs and
tracts were discarded. The cells were subsequently grown into clusters or
small neurospheres using FGF2 at 10 ng/ml for 1–2 weeks (Ben-Hur et
al., 1998). To examine in vitro whether Schwann cells or their precursors
could also be present in this PSA-NCAM-selected population, the PSA-
NCAM1 cells were grown in the same serum-free N2 medium (Ben-Hur
et al., 1998) supplemented with human PDGF AA at 10 ng/ml (R & D
Systems Europe, Abingdon, UK) or 0.1–10 ng/ml FGF2 alone or with
GGF2 at 16–20 ng/ml (courtesy of Mark Marchionni, Cambridge Neu-
roscience, Cambridge, MA) alone or in addition to 0.1–10 ng/ml FGF2
(Sigma, St Louis, MO). Cells plated at 80,000 per well onto uncoated 24
well plates grew into clusters, which, after 10 d of growth, were trans-
ferred to dishes (35 mm; Falcon) coated with Poly-D-lysine and 1 mg/ml
fibronectin (both from Sigma) to allow differentiation in the absence of
FGF2 or PDGF but in the presence of GGF2 in some cases. At 5 d, these
adherent clusters were stained live with mouse IgG1 anti-rat p75 (1:10;
clone 192; Boehringer Mannheim, Mannheim, Germany) followed by
goat anti-mouse IgG-FITC (Jackson ImmunoResearch, West Grove,
PA). In some cases this P75 staining on live cells was combined with
staining with O4 IgM monoclonal antibody followed by goat anti-mouse
IgM-Texas Red (Jackson ImmunoResearch) and fixation in 4%
paraformaldehyde.
Schwann cell cultures and their mixing with PSA-NCAM neural cells.
Schwann cells were isolated from sciatic nerve from newborn Wistar rats
and cultured as described (Dong et al., 1995). Briefly, after dissociation,
fibroblasts were removed by immunopanning with mouse anti-rat Thy-1
antibody (Chemicon, Temecula, CA), and the purified Schwann cells
(95–98% pure) were cultured in DMEM containing 5% fetal calf serum
(FCS). At days 3 and 5, cells were treated for 24 hr with AraC (10 25 M)
to eliminate the remaining fibroblasts. After 6 d in vitro cells were
trypsinized, and 1 million cells were seeded per 35 mm dish in DMEM
and 5% FCS. After 24 hr, this medium was replaced by the modified N2
medium used to cultivate PSA-NCAM-positive CNS precursors (Ben-
Hur et al., 1998). In some dishes, FGF2 (20 ng/ml; Sigma) or GGF2 (20
ng/ml) were added and replenished at 72 and 120 hr. RNA was extracted
after 5 d of culture in modified N2 with factors.
In the mixing experiments, 4 million purified PSA-NCAM1 CNS
precursors were grown into clusters for 5 d with 10 ng/ml of FGF2 as
described (Ben-Hur et al., 1998). At that time, 0, 10, 50, 100, and 1000
purified Schwann cells were added to cluster cultures, which were then
grown for a further 5 d in DMEM-N2 with 10 ng/ml FGF2 before RNA
extraction (see below).
RT-PCR analysis of P0 and P75 expression. Total RNAs were extracted
from PSA-NCAM cell clusters, purified Schwann cells, or PSA-NCAM
cell clusters mixed with various amounts of Schwann cells using the
RNeasy mini kit from Qiagen (Hilden, Germany) following the recom-
mendations of the manufacturer. After spectrophotometric quantifica-
tion, 500 ng–1 mg were retro-transcribed using an oligo-dT primer and
the Superscript II enzyme (Life Technologies, Gaithersburg, MD). Neg-
ative controls in which Supercript was omitted were performed. A 50 ml
PCR reaction was performed using 2 ml of the reverse transcription
reaction as template. To ensure that the PCR signals detected were not
caused by amplification of genomic DNA, control RT-PCR experiments
were performed in which cDNA was synthesized without reverse tran-
scriptase (RT). The sequences of the P0 and actin primers were as
described (Lee et al., 1997; Ben-Hur et al., 1998). The P75 primer
sequences were as follows: TTGCTTGCTGTTGGAATGAG (forward)
and AGCTCCTGGGGAGGAAAATA (reverse), 233 pb.
The PCR reaction contained 5 ml of PCR buffer, 1.5 mM MgCl2, 250 ng
of each primer, 0.2 mM of dNTP mix, and 2.5 U of ampliTaq DNA
polymerase (Perkin-Elmer, Norwalk, CT). The PCR reaction was run
either in a Perkin-Elmer 2400 cycler for the experiments shown in Figure
3 (30 cycles; 94°C for 30 sec, 52°C for 30 sec, and 72°C for 1 min), or in
an MJR PTC200 apparatus (35 cycles; 94°C for 45 sec, 60°C for 45 sec,
and 72°C for 1 min) and was followed by a final extension time at 72°C for
10 min (experiments shown in Fig. 4). Ten microliters of the reaction
were electrophoresed on a 2% agarose gel and colored with ethidium
bromide.
Focal demyelination of adult rats and transplantation of rat neural
precursors. Adult inbred Lewis rats were used in all experiments. Exper-
iments were performed in compliance with Home Office regulations and
institutional guidelines. All operations were performed under fluothane
anesthesia (Janssen Pharmaceuticals, Berse, Belgium). Animals were
x-irradiated 3 d before intraspinal injection of ethidium bromide (n 5
17); the x-irradiation and ethidium bromide demyelination protocols
have been described in detail elsewhere (Blakemore and Crang, 1992).
Forty-eight hours after ethidium bromide injection, clusters were washed
and resuspended in MEM-HEPES at a concentration of ;6 3 10 4
cells/ml. Quantification of cells for transplantation was estimated by
sampling the concentration of clusters and calculating cell density assum-
ing 30 cells per cluster. A 1 ml cell suspension was injected into each
animal using the protocol described in detail elsewhere (Blakemore and
Crang, 1992).
Analysis of remyelination with or without cell transplantation. Trans-
planted (n 5 12) and nontransplanted (n 5 5) animals were killed 30 d
after lesion induction, and the dissected tissue was prepared for light and
electron microscopic examination as previously described (Blakemore
and Crang, 1992). Quantification of oligodendrocyte and Schwann cell
remyelination was conducted on seven transplanted and two nontrans-
planted animals. Toluidine blue-stained transverse 1 mm resin sections
were taken at 1 mm intervals through the lesions and analyzed at 4003
magnification. Each section was viewed in sequential and nonoverlapping
fields using an ocular index grid (Maxta), and oligodendrocyte or
Schwann cell remyelination was determined morphologically under each
point of gridline intersection (the average number of points analyzed per
section was 93). The number of Schwann cell and oligodendrocyte
remyelinated points in each section was then multiplied by an axon
density correction factor, determined by relating the number of axons
within a unit area of Schwann cell remyelination to the number of axons
within a unit area of oligodendrocyte remyelination. The numbers from
each craniocaudal section were then averaged for each animal. The
number of clearly demarcated groups of Schwann cells per lesion was
recorded for each craniocaudal section and then averaged for each
animal.
Protein P0 and Y chromosome labeling. Paraffin wax-embedded sections
were dewaxed, rehydrated, treated with 0.6% hydrogen peroxide and 10
mg/ml proteinase K, and then heated to boiling point in 10 mM citrate
buffer, pH 6, in a microwave oven (O’Leary and Blakemore, 1997).
Anti-P0 monoclonal antibody was applied at a dilution of 1:200. Second-
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ary antibody was biotinylated goat anti-mouse heavy and light chain
(Sigma). Vectastain ABC (Vector Laboratories, Burlingame, CA) and
3,39-diaminobenzidine were used for signal visualization. In situ hybrid-
ization for the Y chromosome was done as previously described
(O’Leary and Blakemore, 1997). For double labeling, P0 immunohisto-
chemistry was performed as above; then sections were treated with
proteinase K, and the Y chromosome-specific probe was applied to
dehydrated sections as described (O’Leary and Blakemore, 1997).
RESULTS
PSA-NCAM1 precursors remyelinate the CNS
after transplantation
PSA-NCAM1 neural precursors from postnatal day 1 inbred
Lewis rat pups were expanded on a nonadherent surface with
FGF2, resulting in the generation of cell clusters after 1–2 weeks
(Fig. 1A). The initial purification yields 85–90% PSA-NCAM1
cells with most of the remaining cells having an O-2A progenitor
phenotype (Ben-Hur et al., 1998). The latter were selected
against by growing the PSA-NCAM1 neural precursors on a
nonadherent surface, resulting in the formation of clusters. These
clusters were then transplanted into areas of ethidium bromide-
induced demyelination made in the x-irradiated spinal cord of
adult Lewis rats. One month after grafting, thoroughly remyeli-
nated lesions were repopulated with astrocytes, oligodendrocytes,
and Schwann cells, whereas no remyelination was observed in
nontransplanted animals (Table 1, Fig. 1, compare B, C). Al-
though axons were primarily remyelinated by oligodendrocytes
(81% of remyelinated axons on average), there were also numer-
Figure 1. Cluster transplantation results in remyelination. A, Phase micrograph of PSA-NCAM1 neural clusters after 10 d in vitro on a nonadherent
surface (immediately before transplant). Grafts consisted of ;60,000 cells in clusters. B, Toluidine blue-stained transverse section of an x-irradiated
ethidium bromide lesion in the dorsal funiculus after 30 d. Besides macrophages containing myelin debris (M ), the lesion contains naked axons tightly
apposed to each other with no evidence of remyelination or glial cell nuclei. C, Toluidine blue-stained transverse section of an x-irradiated ethidium
bromide lesion 30 d after transplantation of PSA-NCAM1 neural clusters. Macrophages containing myelin debris ( M ), oligodendrocytes (O), astrocytes
(A), and Schwann cells (S) are present, and virtually all axons are remyelinated. D, Electron micrograph of an x-irradiated ethidium bromide lesion 30 d
after transplantation of PSA-NCAM1 neural clusters. An oligodendrocyte (O) is present among remyelinated axons, characterized by thin myelin
sheaths. Schwann cells (S), with their nuclei closely apposed to myelin sheaths, are also evident. E, Electron micrograph of an x-irradiated ethidium
bromide lesion 30 d after transplantation of PSA-NCAM1 neural clusters. The myelin sheaths produced by Schwann cells have a greater periodicity than
oligodendrocyte myelin and are surrounded by basement membranes (BM ). Magnification: A, 4003; B, C, 6003; D, 12,0003; E, 25,0003.
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ous aggregates of myelin-forming Schwann cells (19% of remy-
elinated axons on average), which were distributed randomly
throughout the lesions (Fig. 1C,D, Table 1). Schwann cells were
identified on the basis of the presence of a basal lamina and close
apposition of their cytoplasm and nucleus to a myelin sheath that
had the periodicity of PNS rather than CNS myelin (Fig. 1D,E).
In addition, immunoreactivity for protein P0 (the major protein
of peripheral nerve myelin which is made by Schwann cells and is
absent from CNS myelin) was a feature of these groups of
myelinating cells (Fig. 2A).
Remyelinating Schwann cells are transplant-derived
Because remyelination is never observed in nontransplanted
x-irradiated ethidium bromide lesions (Blakemore and Crang,
1988, 1989; Crang et al., 1992; Groves et al., 1993; Franklin et al.,
1996), the Schwann cells present within the remyelinated lesions
can be considered to have been generated from the transplanted
cells. However, to directly establish the transplant origin of these
Schwann cells, we prepared PSA-NCAM1 neural precursors
from male rat brain and grafted them into female recipients. This
allowed us to distinguish between host and transplanted cells
using a Y chromosome-specific probe (Harvey et al., 1992;
O’Leary and Blakemore, 1997). In situ hybridization with this
probe at 1 month after transplantation revealed that male cells
were detected in the lesion and in particular that the cells closely
associated with the P0-immunoreactive myelin sheaths were pos-
itive for the Y chromosome probe (Fig. 2B,C). These experi-
ments therefore confirm that the Schwann cells in the lesions
originated from the transplanted PSA-NCAM1 cell preparation.
Schwann cells are unlikely contaminants of
PSA-NCAM1 CNS precursor clusters
The presence of transplant-derived remyelinating Schwann cells
raised the possibility of contamination of the initial cell prepara-
tion with Schwann cells, because this had previously been dem-
onstrated after the transplantation of mixed glial cell preparations
(Blakemore and Crang, 1988, 1989). Expression of P0 transcripts
is detected in early Schwann cell precursors as well as in neonatal
Schwann cells and therefore is a highly specific marker of the
Schwann cell lineage (Lee et al., 1997). Another gene of interest
is the low-affinity NGF receptor P75 expressed in nonmyelinating
Schwann cells and in multipotential neural crest cells from which
Schwann cells derive (Stemple and Anderson, 1992; You et al.,
1997). To determine whether Schwann cells and/or their precur-
sors were present in the immunoselected PSA-NCAM1 neural
precursor preparation and/or the growing clusters in vitro, we first
examined P0 expression by RT-PCR in RNAs prepared from
immunopurified PSA-NCAM1 neural precursors and after 2
weeks of growth in FGF2. No signal was detected in these two
conditions, whereas P0 mRNA was readily detected in newborn
rat sciatic nerve (Fig. 3A). Generation of Schwann cells may
require neuregulin (NRG) isoforms encoded by the NRG1 gene
and known to trigger survival of early precursors and mitosis of
neonatal Schwann cells (Jessen and Mirsky, 1997). We therefore
added one of the NRG isoforms, GGF2, together with FGF2 to
the growing PSA-NCAM1 precursors for 10 d. This treatment
did not induce the expression of the P0 gene, even after adhesion
and differentiation (Fig. 3B). Yet, P0 expression by Schwann cells
could have been inhibited by FGF2 (Morgan et al., 1994), which
is a growth factor necessary to expand the CNS PSA-NCAM
precursors. To exclude this possibility, we examined by RT-PCR
whether P0 expression was inhibited in purified neonatal Schwann
cells grown for 5 d in the same FGF2-containing medium as the
PSA-NCAM clusters, in GGF-containing medium, or in medium
without growth factors. We found P0 signal in each condition
(Fig. 4A). P75 expression was also detected in these three condi-
tions, as predicted for Schwann cells cultured in the absence of
neurons. Thus our detection system should trace Schwann cell P0
expression in the PSA-NCAM clusters.
There was still the possibility that Schwann cells were initially
present but in insufficient numbers to be detected by P0 RT-PCR
assay. To address this question, we mixed small but increasing
numbers of Schwann cells to the PSA-NCAM1 CNS clusters, and
after 5 d of growth in FGF2, we analyzed the expression of P0 by
RT-PCR (Fig. 4B). P0 signal was detected after addition of 100
Schwann cells to clusters developed from 4 million PSA NCAM1
cells but was absent when ,100 Schwann cells were added to the
clusters. This indicated that ,1 Schwann cell in 40,000 PSA
NCAM1 cells could have been present in the initial preparation
without producing a P0 signal detectable by RT-PCR. Because no
P0 signal emerged when CNS clusters were grown in the presence
Table 1. Remyelination by oligodendrocytes and Schwann cells
Animal
Axons
remyelinated
(%)
Axons remyelinated by
oligodendrocytes (%)
Axons
remyelinated by
Schwann cells (%)
Average no.
of Schwann
cell-remyelinated
areas/section
1 99 79 (76–81) 21 (19–24) 16 (11–22)
2 98 78 (73–84) 22 (16–27) 18 (15–24)
3 98 83 (77–88) 17 (12–23) 12 (10–14)
4 95 81 (78–83) 19 (17–22) 16 (10–21)
5 97 82 (76–93) 18 (7–23) 17 (12–21)
6 100 83 (78–87) 17 (13–22) 15 (13–15)
7 100 83 (80–84) 17 (15–20) 11 (9–11)
8 0 0 0 0
9 0 0 0 0
Percentage of remyelinated axons within lesions and the relative contribution of oligodendrocytes and Schwann cells to
remyelination. Although all animals were x-irradiated and demyelinated, only those animals that received a graft (1–7)
were remyelinated; nongrafted animals (8 and 9) showed no evidence of remyelination. The percentage of remyelinated
axons and the percentage of those remyelinated by oligodendrocytes or Schwann cells were not significantly different
throughout the craniocaudal length of each of the lesions. Each remyelinated section contained an average of 15 distinct
Schwann cell remyelinated areas, indicating clonal expansion at multiple sites. Ranges are given in parentheses.
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of GGF2 (Fig. 3B), we conclude that putative contaminating
Schwann cells were very rare or absent and did not expand in vitro
PSA-NCAM1 CNS precursor clusters contain
occasional P751 cells
The P75 signal was examined in the mixing experiment described
above and was found to increase progressively with the numbers
of Schwann cells added to the clusters (Fig. 4B). Interestingly, a
faint P75 signal was seen in clusters without added Schwann cells,
suggesting the presence of rare neural crest cells or early Schwann
cell precursors. Accordingly, immunofluorescence revealed the
presence of one or two round or bipolar P751 cells in 7–8.6% of
the clusters grown in PDGF or FGF2 and in 9.2–13.4% of the
clusters grown with GGF2 added to PDGF or FGF2 (Fig. 5).
These P751 precursors did not increase in number with time in
the clusters, and, after adhesion, no groups of P751 cells with a
Schwann cell bipolar phenotype were seen in the migration zone,
Figure 2. Remyelinating Schwann cells are transplant-derived. A, P0-immunostained transverse section of an x-irradiated, ethidium bromide-lesioned
dorsal funiculus 30 d after transplantation of PSA-NCAM1 neural clusters. P0 immunostaining demonstrates many foci of Schwann cell myelination
scattered throughout the lesion. B, Computerized overlay of serial tissue sections hybridized with Y chromosome probe (blue) and immunostained with
P0 antibodies for Schwann cell myelin ( yellow) in an x-irradiated, ethidium bromide-lesioned female rat 30 d after transplantation of PSA-NCAM1
neural clusters prepared from male donors. The foci of Schwann cell myelin correspond to regions of high density of transplanted cells. C, P0 and Y
chromosome double-labeled transverse section of an x-irradiated, ethidium bromide-lesioned female rat 30 d after transplantation of PSA-NCAM1
neural clusters prepared from male donors. Intimate apposition of P0-immunostained Schwann cell myelin with Y chromosome-hybridized cell bodies
is shown. Magnification: A, 2003; B, 3003; C, 4003.
Figure 3. P0 expression is not detected in the graft preparations. A, RT-PCR of total RNAs extracted from newborn rat sciatic nerve and PSA-NCAM1
cells just after immunopanning (Day 0), after 2 weeks of culture on nonadherent surface in FGF2 (2 wk Cl.), or after differentiation of growing clusters
obtained by transfer to poly-D-ornithine-coated surfaces (Diff. Cl.). P0 expression is absent in PSA-NCAM1 cells in all three experimental conditions.
A molecular size marker (174 DNA digested with HaeIII) was run on the right and lef t. Controls for RT-PCR (RT ) correspond to cDNA synthesized
without reverse transcriptase. B, Immunopurified precursors were treated for 14 d in vitro with both FGF2 and GGF2. Cell clusters were then transferred
to adherent surfaces for differentiation (as in A) for 5 d without any growth factor. RNA extraction and the positive controls are as in A. Although GGF
treatment was performed for 14 d, no P0 expression was observed during in vitro growth and differentiation of the PSA-NCAM precursors.
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as would be expected if Schwann cells were generated from neural
crest precursors in vitro Moreover, P0 RT-PCR signal was absent
after differentiation of cell clusters for 5 d (Fig. 3A). However,
there were many multiprocessed cells with a phenotype typical of
oligodendrocytes that were strongly immunostained with the O4
antibody but only weakly with the P751 antibody (Casaccia-
Bonnefil et al., 1996). These results suggest that P751 neural
crest, or early Schwann cell precursors of CNS origin, may de-
velop in the clusters. However, these putative Schwann precursors
did not generate increasing numbers of Schwann cells in vitro even
in the presence of GGF.
Analysis of toluidine blue-stained sections of the grafted ani-
mals showed that Schwann cell remyelinated areas were present
throughout the remyelinated lesions in all animals, on average 15
Schwann cell remyelinated areas per section (Table 1). The high
number of Schwann cell foci indicated that Schwann cells were
generated by clonal expansion at multiple sites. The multiple
Schwann cell foci and the detection of only small numbers of
P751 putative neural crest cells in vitro suggest that the P751
cells are unlikely to be the sole source of the Schwann cells
present in the lesions and that the majority of Schwann cells were
generated from the PSA-NCAM1 neural precursors in response
to the glia-free, axon-rich environment of the demyelinating
lesion.
DISCUSSION
We have generated from the newborn rat brain a CNS donor cell
population that is readily expanded in vitro, has a mostly glial fate
(Ben-Hur et al., 1998), and results in complete remyelination of
demyelinated axons after transplantation in adult rats (Table 1).
The extent of remyelination surpassed that observed after trans-
plantation of O-2A progenitor cells (grown with PDGF and
FGF2) into similar demyelinated lesions in which a mean of 60%
of axons were remyelinated (Groves et al., 1993). Because PSA-
NCAM expression precedes oligodendrocyte progenitor antigen
expression (Grinspan and Franceschini, 1995), our findings ex-
tend previous observations that early precursors of oligodendro-
cytes have a greater remyelinating capacity than cells at more
differentiated stages of the lineage (Warrington et al., 1993;
Crang and Blakemore, 1997). Thus, with their potential for ex-
pansion in vitro, PSA-NCAM1 neural precursors represent an
ideal cell population for therapy of chronic demyelinated lesions.
Recent studies indicate that human neural precursors express
PSA-NCAM (Murray and Dubois-Dalcq, 1997) and can be ex-
Figure 4. P0 and P75 transcripts are detected in purified Schwann cells and in Schwann cells mixed with PSA-NCAM clusters. RT-PCR of total RNAs
extracted from purified Schwann cells ( A) or PSA-NCAM CNS clusters to which increasing small numbers of Schwann cells were added ( B) is shown.
A, Signals for P0 and P75 were detected when 1 million Schwann cells were grown in FGF2, GGF2, or defined medium for 5 d. The most intense signal
was seen for P75, and the P0 signal was weaker in defined medium alone. P0 signal is observed in Schwann cells cultivated with FGF2 or GGF. B, P0
is observed clearly in the mix of 4 million PSA-NCAM CNS precursors with 100 Schwann cells. These results mean that RT-PCR could detect 0.0025%
Schwann cell contamination in the PSA-NCAM1 clusters. P75 shows a faint signal in the absence of Schwann cells, and that signal increases in intensity
proportionally with the number of Schwann cells added. In contrast, the actin signal (seen at 800 MW) displays equal intensity when 10, 50, or 100
Schwann cells were added.
Figure 5. Immunofluorescence staining of a P751 precursor cell in a
PSA-NCAM cluster. Immunopurified PSA-NCAM1 cells were grown for
10 d in FGF2 and GGF2 on a nonadherent surface. After adherence they
were immunolabeled with P75 antibody, followed by FITC-conjugated
secondary antibody. Shown here is one (or two?) P751 cells with short
processes located inside an adherent cluster (delineated by white arrows).
These cells did not co-stain with O4 or GFAP. Magnification, 4003.
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panded with FGF2 (Sabate et al., 1995; Svendsen et al., 1996;
Chalmers-Redman et al., 1997; Murray and Dubois-Dalcq, 1997),
suggesting that human precursors with a differentiation and re-
myelination potential similar to that described here could be
isolated.
Transplantation not only provides a means of evaluating remy-
elinating potential of cell preparations but also provides an effec-
tive way of evaluating the differentiation potential of multipotent
cells (Renfranz et al., 1991; Snyder et al., 1992; Vicario-Abejon et
al., 1995; Shihabuddin et al., 1996). When neural precursor cells
are implanted into different areas of the developing nervous
system, they generate progeny that would normally be generated
in that area at the time the cells are grafted. Thus, the same
precursor cells can generate Purkinje cells when implanted into
the cerebellum and hippocampal neurons when introduced into
the hippocampus at the time that these cells are being generated
from endogenous precursors (Renfranz et al., 1991). Similarly,
when multipotent cells are implanted into pathological areas of
the CNS, their differentiation potential is influenced by the en-
vironment into which they are placed. Thus, multipotent rat
progenitors introduced into the myelin-deficient rat generate only
oligodendrocytes (Hammang et al., 1997), while multipotent hu-
man progenitors placed into dopaminergic lesions generate neu-
rons and astrocytes (Svendsen et al., 1997). The differentiation of
transplanted multipotent cells is therefore strongly influenced by
the environmental signals and cellular deficiencies operating at
the site of implantation.
The PSA-NCAM1 neural precursors used in this study were
isolated from brain hemispheres and the subventricular zone
(SVZ) that gives rise to glial cells in the postnatal rat brain
(Goldman, 1995). Other populations of CNS cells that express
PSA-NCAM may have different fates or potentiality. The anterior
SVZ gives rise to PSA-NCAM1 neuronal progenitors, which
migrate throughout life in the rostral migratory stream and gen-
erate olfactory bulb neurons (Alvarez-Buylla, 1997; Wichterle et
al., 1997). The neonatal cerebral cortex contains epidermal
growth factor (EGF)-responsive PSA-NCAM1 precursors able
to generate neurons and glia (Marmur et al., 1998). However,
neurons are rarely observed when our PSA-NCAM1 cell popu-
lations grown in FGF2 and thyroid hormone are allowed to
differentiate in vitro (Ben-Hur et al., 1998). In addition, PSA-
NCAM-negative neural precursors—excluded by the immunos-
election—are multipotential when grown in EGF, whereas they
generate more glia when grown in FGF2 and T3 (Ben-Hur et al.,
1998). Together these observations indicate that the neonatal
PSA-NCAM1 neural precursors used in the present study be-
come restricted to a glial fate during their in vitro expansion.
However, we cannot exclude that cortical precursors or olfactory
neuron progenitors, if present, may have switched to a glial fate in
vitro or after grafting in the spinal cord demyelinating lesion.
Some olfactory bulb-ensheathing cells can also express PSA-
NCAM (Franceschini and Barnett, 1996) and generate a myeli-
nating cell with a Schwann cell phenotype after transplantation
into ethidium bromide spinal cord lesions (Franklin et al., 1996).
Although contamination of our neural precursor populations by
these cells is a possibility, care was taken to separate olfactory
bulbs from the cerebral hemispheres for the preparation of the
mixed glial cell cultures (Ben-Hur et al., 1998). In addition,
olfactory glial cells require astrocyte-conditioned medium or
serum for their growth (Franceschini and Barnett, 1996), con-
ditions that were not used to grow our precursors. Thus, the
presence within our graft preparations of sufficient numbers of
olfactory bulb-ensheathing cells to generate the numerous and
dispersed Schwann cell foci within the lesions appears highly
unlikely.
Transplantation of PSA-NCAM1 neonatal neural precursors
into the glia-free environment of x-irradiated ethidium bromide
lesions revealed an unexpected potential of these precursors to
generate Schwann cells in addition to oligodendrocytes and as-
trocytes. Thus the differentiation potential of PSA-NCAM1 neu-
ral precursors appears wider in vivo than in vitro where they
generate essentially oligodendrocytes and astrocytes (Ben-Hur et
al., 1998). By transplanting male cells into female animals, we
confirmed that the Schwann cells were transplant-derived. RT-
PCR analysis for P0 gene transcripts, a specific and sensitive
indicator of the Schwann cell lineage (Lee et al., 1997), demon-
strated that Schwann cells or their precursors were absent or rare
within the PSA-NCAM-immunoselected cells at purification and,
if present, were not expanded in vitro with FGF2 or PDGF with
or without GGF2. Our finding of P751 cells inside the clusters
indicates that PSA-NCAM1 neural precursors may have the
ability to generate neural crest cells and/or early Schwann cell
precursors. In support of this is the recent observation that
embryonic neural stem cells derived from the telencephalic re-
gion generate not only the three CNS cell types but also neural
crest cell derivatives in vitro (Hazel et al., 1997). In addition,
studies of spinal cord development with chick–quail chimeras
suggest that multipotential neural precursors located anywhere in
the neural tube have the ability to develop neural crest pheno-
types if they encounter an appropriate environment (Sharma et
al., 1995). Moreover, clonal analysis of multipotential cells from
the rat spinal cord suggests that a common CNS precursor can
generate both CNS and PNS phenotypes (Mujtaba et al., 1998).
Finally, neural stem cells were recently shown to have unexpected
potential to generate cells of the hemopoietic system when en-
grafted into sublethally irradiated animals (Bjornson et al., 1999).
By analogy, we propose that the differentiation potential of PSA-
NCAM1 neural precursors was extended in vivo and that these
cells were instructed to generate both CNS and PNS myelin-
forming cells by signals present within the irradiated demyelinat-
ing lesions devoid of oligodendrocytes and astrocytes.
Our findings demonstrate that selection and subsequent expan-
sion of PSA-NCAM1 neural precursors provides a cell prepara-
tion with excellent remyelination potential after transplantation
into areas of demyelination in the rat. As cultured PSA-NCAM1
clusters synthesize transcripts for several growth factors, includ-
ing PDGF and FGF-2 (T. Ben-Hur, B. Rogister, and M. Dubois-
Dalcq, unpublished observations), which enhance their growth
(Grinspan and Franceschini, 1995; Ben-Hur et al., 1998), the
production of these factors after transplantation of clusters may
contribute to cell survival and differentiation in vivo. Moreover,
expression of PSA-NCAM has been correlated with cell migra-
tion during remyelination (Nait Oumesmar et al., 1995). Because
PSA-NCAM1 cells can be isolated from the embryonic human
CNS (Murray and Dubois-Dalcq, 1997), our results represent an
important step in the development of glial cell transplantation
strategies for the treatment of diseases associated with chronic
demyelination. A further novel observation was that the presence
of axon signals within a lesion devoid of astrocytes revealed an
unexpected potential of PSA-NCAM1 neural precursors to gen-
erate Schwann cells.
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